Waiver of the WTO’s Intellectual Property Rules: Existing TRIPS “Flexibilities” Unworkable for Necessary Scale Up of COVID-19 Medicines Production April 5, 2021
Waiver of the WTO’s Intellectual Property Rules: “Third Way” Is the Same Old Way, Rebranded… March 29, 2021
Backgrounder: WTO-Required Monopolies for Pharmaceutical Corporations Obstruct Global Production of COVID-19 Vaccines & Treatment March 1, 2021